{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nResearch on the inhibitor of myogenic family isoform a (I‐mfa) has revealed its critical role as a molecular switch in the regulation of calcium signaling. I‐mfa interacts directly with TRPC1 through its C-terminal domain, modulating store-operated Ca2+ channels and thereby influencing Ca2+ influx during periods of depleted intracellular Ca2+ stores. This interaction highlights a novel mechanism by which I‐mfa can fine-tune ion channel activity and potentially affect downstream cellular processes."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn the context of extracellular matrix dynamics, I‐mfa has emerged as a pivotal modulator in mesangial cells by promoting the expression of fibronectin—a key component in renal fibrosis. Under high glucose conditions, as seen in diabetic nephropathy, I‐mfa protein levels increase through reactive oxygen species-mediated mechanisms, leading to enhanced fibronectin synthesis. This suggests that aberrant regulation of I‐mfa may contribute to structural and functional alterations observed in diabetic kidney disease."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nMoreover, I‐mfa influences hematopoietic lineage commitment by regulating differentiation signals through MAPK and β-catenin/TCF/LEF pathways, thereby affecting blood cell production and function. Dysregulation of I‐mfa is linked to altered progenitor cell dynamics and has been implicated in myeloid leukemias, underscoring its role in normal and malignant hematopoiesis. In parallel, emerging evidence from circulating microRNA studies in type 2 diabetes mellitus and coronary artery disease contexts—among which MIR4750 is a candidate biomarker—suggests that such microRNAs may interact with pathways involving I‐mfa. Although MIR4750 is not directly described in these mechanistic studies, its association with cardiometabolic conditions positions it as a potential regulator of I‐mfa–dependent processes, linking altered calcium signaling, extracellular matrix remodeling, and hematopoietic differentiation to the pathogenesis of diabetic atherosclerosis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": ""}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Rong Ma, Dana Rundle, Jeanie Jacks, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Inhibitor of myogenic family, a novel suppressor of store-operated currents through an interaction with TRPC1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M309610200"}], "href": "https://doi.org/10.1074/jbc.M309610200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14530267"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14530267"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Parisa Yazdizadeh Shotorbani, Sarika Chaudhari, Yu Tao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Inhibitor of myogenic differentiation family isoform a, a new positive regulator of fibronectin production by glomerular mesangial cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Physiol Renal Physiol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/ajprenal.00508.2019"}], "href": "https://doi.org/10.1152/ajprenal.00508.2019"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31984795"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31984795"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Jeremy S Houser, Maulin Patel, Kyle Wright, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The inhibitor of MyoD Family A (I-MFA) regulates megakaryocyte lineage commitment and terminal differentiation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood Cells Mol Dis (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bcmd.2023.102760"}], "href": "https://doi.org/10.1016/j.bcmd.2023.102760"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37267696"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37267696"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Joanna Szydełko, Marcin Czop, Alicja Petniak, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of plasma miR-4505, miR-4743-5p and miR-4750-3p as novel diagnostic biomarkers for coronary artery disease in patients with type 2 diabetes mellitus: a case-control study."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cardiovasc Diabetol (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12933-024-02374-0"}], "href": "https://doi.org/10.1186/s12933-024-02374-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "39080630"}], "href": "https://pubmed.ncbi.nlm.nih.gov/39080630"}]}]}]}